INS and type 2 diabetes mellitus: Specifically, serum chemerin levels have been found to be reduced in individuals with T2DM, while mouse islet β cells exhibit an abundant expression of chemerin, and the addition of chemerin in vitro has been shown to increase insulin secretion [8,20].